NCT00002789
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +12 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
Clinical trial condition
Leukemia, Myeloid, Chronic-Phase
Explore clinical trials studying Leukemia, Myeloid, Chronic-Phase. Study availability and eligibility vary by location and protocol.
314 public trials
21 recruiting studies
Leukemia, Myeloid, Chronic-Phase trial results
NCT00255710
- Conditions
- Amyloidosis, Anemia, Anemia, Refractory, +66 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
NCT00003082
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
- Locations
-
- Arizona Cancer Center Tucson, Arizona, United States
NCT00015925
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +43 more
- Locations
-
- Greenebaum Cancer Center at University of Maryland Medical Center Baltimore, Maryland, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
Completed
Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
NCT00006042
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +54 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
NCT00003187
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +27 more
- Locations
-
- Stanford University Medical Center Stanford, California, United States
- University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
- Albert B. Chandler Medical Center, University of Kentucky Lexington, Kentucky, United States
- University of Minnesota Medical School Minneapolis, Minnesota, United States
NCT00510926
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +12 more
- Locations
-
- Policlinico S.Orsola-Malpighi, Istituto di Ematologia e Oncologia Medica "L. e A. Seràgnoli" Bologna, Italy
Active, Not Recruiting
Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant
NCT02506933
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, +43 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase
NCT05143840
- Conditions
- Adult CML, Bone Marrow Diseases, Chronic Disease, +14 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Winship Cancer Institute Emory University Atlanta, Georgia, United States
- Georgia Cancer Center at Augusta University Augusta, Georgia, United States
- Karmanos Cancer Institute Detroit, Michigan, United States
Active, Not Recruiting
Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease
NCT03516279
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, +15 more
- Locations
-
- Fairbanks Memorial Hospital Fairbanks, Alaska, United States
- CTCA at Western Regional Medical Center Goodyear, Arizona, United States
- Cancer Center at Saint Joseph's Phoenix, Arizona, United States
- Mercy Hospital Fort Smith Fort Smith, Arkansas, United States